Global Oral Vaccine for Human Market Growth 2023-2029

Global Oral Vaccine for Human Market Growth 2023-2029

The global Oral Vaccine for Human market size is projected to grow from US$ 2484.8 million in 2022 to US$ 3707.1 million in 2029; it is expected to grow at a CAGR of 5.9% from 2023 to 2029.

United States market for Oral Vaccine for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Oral Vaccine for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Oral Vaccine for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Oral Vaccine for Human players cover Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. 

LPI (LP Information)' newest research report, the “Oral Vaccine for Human Industry Forecast” looks at past sales and reviews total world Oral Vaccine for Human sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Vaccine for Human sales for 2023 through 2029. With Oral Vaccine for Human sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Vaccine for Human industry.

This Insight Report provides a comprehensive analysis of the global Oral Vaccine for Human landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Vaccine for Human portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Vaccine for Human market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Vaccine for Human and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Vaccine for Human.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccine for Human market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Segmentation by application
Public
Private

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Vaccine for Human market?

What factors are driving Oral Vaccine for Human market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Vaccine for Human market opportunities vary by end market size?

How does Oral Vaccine for Human break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.